49
Views
0
CrossRef citations to date
0
Altmetric
Articles

Isolation and Identification of Pinocembrin-7-O-[4”, 6"-(S)-Hexahydroxy Diphenoyl]-β-D-Glucose from Macrosolen capitellatus: In vitro and In silico Studies to Explore its Anticancer Potential

, , , , , , & show all
Pages 177-182 | Received 13 Apr 2020, Accepted 15 Jun 2020, Published online: 13 Jul 2020
 

Abstract

Mistletoes are extremely important plants and their extracts have been widely used as a complementary medicine towards cancer therapy. In this context, we have studied the leaves of a South Indian Mistletoe, Macrosolen capitellatus (Wight & Arn.) Danser, a parasitic plant belonging to family Loranthaceae. A bioassay-guided isolation and LC-MS dereplication strategies have led to the isolation of pinocembrin-7-O-[4”, 6"-(S)-hexahydroxy diphenoyl (HHDP)]-β-D-glucose (1). This is the first report showing the presence of 1 not only in this plant but also in the genus Macrosolen. In this study, the aforementioned parasitic plant was collected from two different host plants, Mangifera indica and Phyllanthus emblica, which were extensively studied chemically by various research groups. We have observed that 1 is present in both samples of M. capitellatus, while a thorough literature search showed that this compound 1 has not been reported from either Mangifera indica or Phyllanthus emblica. These observations indicated that the producer of 1 is nothing but parasitic plant M. capitellatus. This compound has shown moderate anti-proliferative activity against MCF-7 cell line (IC50 value-15 μM). A computational protein binding study has been performed on 1 against 25 crystallographic proteins of the BRCA-1 gene of breast cancer. The results showed interactions having -9.33 and -8.99 kcal/mol binding energy with the proteins IDs 1T15 and 1T29 respectively; which suggests that this scaffold has the potential to develop further.

GRAPHICAL ABSTRACT

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.